HENRY SCHEIN INC (HSIC) Stock News
NASDAQ:HSIC - Nasdaq - US8064071025 - Common Stock - Currency: USD
HSIC Latest News, Press Relases and Analysis
Top S&P500 movers in Wednesday's session
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
3 Small-Cap Stocks Walking a Fine Line
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and worst performers in the dental equipment & technology industry.
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and worst performers in the dental equipment & technology industry.
Henry Schein to Participate in Upcoming Investor Conference in March
Nominations Now Open for Henry Schein Medical’s Athletics and Schools 2025 Rising Star Award
Henry Schein (NASDAQ:HSIC) Reports Sales Below Analyst Estimates In Q4 Earnings
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ consensus estimates.
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
Henry Schein (HSIC) Q4 Earnings Report Preview: What To Look For
Dental and Medical products company Henry Schein (NASDAQ:HSIC) will be reporting results tomorrow morning. Here’s what investors should know.
3 Reasons HSIC is Risky and 1 Stock to Buy Instead
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.3% to $77.62 per share while the index has gained 12.2%.
Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children
Mentions: CL
Henry Schein Medical Honors Women Trailblazers in Athletic Training on National Girls and Women in Sports Day 2025
KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal
The private equity firm will also be able to purchase additional shares via open market purchases, up to a total equity stake of 14.9% in Henry Schein.
Mentions: KKR
KKR Takes Strategic Stake in Medical Supply Group Henry Schein
KKR & Co. has taken a 12% strategic stake in Henry Schein Inc and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.
Mentions: KKR
Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET
Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein
/PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Acentus in the acquisition...
Henry Schein Completes Acquisition of Acentus
